Fig. 1From: Evaluation of pregnancy outcomes from the Tysabri® (natalizumab) pregnancy exposure registry: a global, observational, follow-up studyPatients enrolled and outcome of pregnancy. aEight completed pregnancies resulted in twin birthsBack to article page